(Q34083391)

30 July 2017

1 reference

title

Copper control as an antiangiogenic anticancer therapy: lessons from treating Wilson's disease (English)

1 reference

30 July 2017

Copper Control as an Antiangiogenic Anticancer Therapy: Lessons from Treating Wilson's Disease (English)

0 references

main subject

copper

0 references

angiogenesis inhibitor

1 reference

Brewer GJ

1

1 reference

30 July 2017

George J. Brewer

series ordinal

1

0 references

publication date

1 July 2001

1 reference

Experimental Biology and Medicine

30 July 2017

July 2001

0 references

published in

1 reference

30 July 2017

volume

226

1 reference

30 July 2017

issue

7

1 reference

30 July 2017

page(s)

665-673

1 reference

Treatment of Wilson's disease with zinc: XV long-term follow-up studies

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Penicillamine, a new oral therapy for Wilson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

A comparison of the effects of penicillamine, trientine, and trithiomolybdate on [35S]-labeled metallothionein in vitro; implications for Wilson's disease therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Factors promoting tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Gangliosides, copper ions and angiogenic capacity of adult tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Mechanisms of angiogenesis in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Vascular endothelial growth factor: an important angiogenic mediator in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Role of vascular endothelial growth factor in the regulation of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Growth factor release from amylopectin hydrogel based on copper coordination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Purified monocyte-derived angiogenic substance (angiotropin) stimulates migration, phenotypic changes, and "tube formation" but not proliferation of capillary endothelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Interaction of human angiogenin with copper modulates angiogenin binding to endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

SPARC is a source of copper-binding peptides that stimulate angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Copper concentration and cytochrome-oxidase and ribonuclease activities in the brains of copper-deficient lambs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Histopathology of enzootic ataxia in Sika deer (Cervus nippon Temminck).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Evidence for the Saccharomyces cerevisiae ferrireductase system being a multicomponent electron transport chain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Evidence for Cu(II) reduction as a component of copper uptake by Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Homeostatic regulation of copper uptake in yeast via direct binding of MAC1 protein to upstream regulatory sequences of FRE1 and CTR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

Mitochondrial DNA rearrangements of Podospora anserina are under the control of the nuclear gene grisea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020222600712

10.1177/153537020222600712

21 January 2018

Identifiers

DOI

0 references

1 reference